Please login to the form below

Not currently logged in
Email:
Password:

Cervarix

This page shows the latest Cervarix news and features for those working in and with pharma, biotech and healthcare.

GSK's Bexsero vaccine growing fast, despite "tight" supply

GSK's Bexsero vaccine growing fast, despite

A few weeks ago the company ceded the US cervical cancer vaccine market to Merck &Co after withdrawing its Cervarix product, finding it was not competitive.

Latest news

More from news
Approximately 2 fully matching, plus 78 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics